Findings of hypocretin (HCRT), also named orexin, deficiency in cerebrospinal fluid (CSF), and recent data on the involvement of the immune system in narcolepsy [8, 9] opened research for new diagnostic and treatment options. The gene discussed is HCRT; the disease is narcolepsy.